Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T09:17:43.459Z Has data issue: false hasContentIssue false

Impact of fluoroquinolone cascade reporting of urine samples on antibiotic prescribing rates in a network of urgent care clinics

Published online by Cambridge University Press:  20 June 2022

Brittani M. Weichman
Affiliation:
Department of Pharmacy, UnityPoint Health, Des Moines, Iowa
Amanda M. Bushman
Affiliation:
Department of Pharmacy, UnityPoint Health, Des Moines, Iowa
Kathie L. Rogers
Affiliation:
Pathology Laboratory, Des Moines, Iowa
Rossana Rosa*
Affiliation:
Department of Medicine, University of Iowa-Des Moines, Des Moines, IowaInfectious Diseases Service, UnityPoint Health, Des Moines, Iowa (Present affiliations: Microbiology Laboratory, Nebraska Medicine, Omaha, Nebraska [K.L.R.] and Department of Quality and Patient Safety, Jackson Health System, Miami, Florida [R.R.])
*
Author for correspondence: Rossana Rosa, MD, MSc, Infection Prevention and Antimicrobial Stewardship, Jackson Health System, 1611 NW 12th Avenue, Miami, FL 33136. E-mail: rossana.rosa@jhsmiami.org

Abstract

Cascade reporting is an antimicrobial stewardship strategy that has been successfully implemented in inpatient settings, but evidence of its impact on outpatient settings is scarce. We report on the impact on fluroquinolone prescribing at a network of urgent care clinics following the implementation of cascade reporting of Enterobacterales in urine cultures.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Fig. 1.Antimicrobial susceptibility reporting rules for urine cultures with growth of Enterobacterales. Note. TMP-SMX, trimethoprim-sulfamethoxazole; A-S, ampicillin-sulbactam; P-T, piperacillin-tazobactam.

Figure 1

Fig. 2.Rates of antibiotic use before and after implementation of fluoroquinolone cascade reporting at urgent care and express care clinics, July 2018–December 2020.